Literature DB >> 20547906

Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results.

Sheldon R Morris1, Susan J Little, Terry Cunningham, Richard S Garfein, Douglas D Richman, Davey M Smith.   

Abstract

BACKGROUND: Nucleic acid testing (NAT) in routine HIV testing programs can increase the detection of infected individuals, but the most effective implementation of NAT remains unclear.
OBJECTIVE: To determine how many HIV cases can be identified with NAT and how many persons can be contacted, to identify predictors of acute and early HIV infection cases, and to test reporting of negative results by automated Internet and voicemail systems.
DESIGN: Prospective study.
SETTING: San Diego County, California. PARTICIPANTS: Persons seeking HIV testing. MEASUREMENTS: Rates and predictors of HIV infection by stage, notification of positive NAT results, use of automated Internet or voicemail systems to access negative NAT results, and estimated HIV infections prevented.
RESULTS: Of 3151 persons tested, 79 had newly diagnosed cases of HIV: 64 had positive results from rapid HIV test, and 15 had positive results only by NAT (that is, NAT increased the HIV detection yield by 23%). Of all HIV infections, 44% (in 35 persons) were in the acute and early stages. Most participants (56%) and persons with HIV (91%) were men who have sex with men (MSM). All persons with NAT-positive results were notified within 1 week. Of all 3070 uninfected patients, 2105 (69%) retrieved their negative NAT results, with 1358 using the Internet system. After adjustment for covariates, persons reporting MSM behavior, higher incomes, younger ages, no testing at substance abuse rehabilitation centers, no recent syphilis, and no methamphetamine use were more likely to access negative NAT results by either Internet or voicemail systems. LIMITATION: Findings may not be generalizable to other populations and testing programs.
CONCLUSION: Nucleic acid testing programs that include automated systems for result reporting can increase case yield, especially in settings that cater to MSM.

Entities:  

Mesh:

Year:  2010        PMID: 20547906      PMCID: PMC2922925          DOI: 10.7326/0003-4819-152-12-201006150-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  36 in total

1.  Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence.

Authors:  Denise Kothe; Robert H Byers; Samuel P Caudill; Glen A Satten; Robert S Janssen; W Harry Hannon; Joanne V Mei
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-15       Impact factor: 3.731

2.  The process of seeking sex partners online and implications for STD/HIV prevention.

Authors:  S Salyers Bull; M McFarlane; L Lloyd; C Rietmeijer
Journal:  AIDS Care       Date:  2004-11

3.  The Internet as a newly emerging risk environment for sexually transmitted diseases.

Authors:  M McFarlane; S S Bull; C A Rietmeijer
Journal:  JAMA       Date:  2000-07-26       Impact factor: 56.272

4.  Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

Authors:  Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Xianbin Li; Oliver Laeyendecker; Noah Kiwanuka; Godfrey Kigozi; Mohammed Kiddugavu; Thomas Lutalo; Fred Nalugoda; Fred Wabwire-Mangen; Mary P Meehan; Thomas C Quinn
Journal:  J Infect Dis       Date:  2005-03-30       Impact factor: 5.226

5.  Outcomes of offering rapid point-of-care HIV testing in a sexually transmitted disease clinic.

Authors:  Sabrina R Kendrick; Karen A Kroc; David Withum; Robert J Rydman; Bernard M Branson; Robert A Weinstein
Journal:  J Acquir Immune Defic Syndr       Date:  2005-02-01       Impact factor: 3.731

6.  Failure to return for HIV posttest counseling in an STD clinic population.

Authors:  Lisa B Hightow; William C Miller; Peter A Leone; David Wohl; Marlene Smurzynski; Andrew H Kaplan
Journal:  AIDS Educ Prev       Date:  2003-06

7.  Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.

Authors:  Susan L Stramer; Simone A Glynn; Steven H Kleinman; D Michael Strong; Sally Caglioti; David J Wright; Roger Y Dodd; Michael P Busch
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

8.  Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population.

Authors:  Christopher D Pilcher; J Todd McPherson; Peter A Leone; Marlene Smurzynski; Judy Owen-O'Dowd; Amy L Peace-Brewer; Juanita Harris; Charles B Hicks; Joseph J Eron; Susan A Fiscus
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272

9.  Use of the Internet and e-mail for health care information: results from a national survey.

Authors:  Laurence Baker; Todd H Wagner; Sara Singer; M Kate Bundorf
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men.

Authors:  C J Reback; S Larkins; S Shoptaw
Journal:  AIDS Care       Date:  2003-12
View more
  37 in total

1.  Evaluation of pooled rapid HIV antibody screening of patients admitted to a San Diego Hospital.

Authors:  Sanjay R Mehta; Vu T Nguyen; Georgina Osorio; Susan Little; Davey M Smith
Journal:  J Virol Methods       Date:  2011-04-12       Impact factor: 2.014

2.  Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.

Authors:  Gabriel A Wagner; Elise Landais; Gemma Caballero; Pham Phung; Sergei L Kosakovsky Pond; Pascal Poignard; Douglas D Richman; Susan J Little; Davey M Smith
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

3.  Development and validation of the San Diego Early Test Score to predict acute and early HIV infection risk in men who have sex with men.

Authors:  Martin Hoenigl; Nadir Weibel; Sanjay R Mehta; Christy M Anderson; Jeffrey Jenks; Nella Green; Sara Gianella; Davey M Smith; Susan J Little
Journal:  Clin Infect Dis       Date:  2015-04-22       Impact factor: 9.079

4.  Sexual Partner Concurrency Among Partners Reported by MSM with Recent HIV Infection.

Authors:  Heather A Pines; Maile Y Karris; Susan J Little
Journal:  AIDS Behav       Date:  2017-10

5.  Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles.

Authors:  Jouni Vesa; Antoine Chaillon; Gabriel A Wagner; Christy M Anderson; Douglas D Richman; Davey M Smith; Susan J Little
Journal:  AIDS       Date:  2017-05-15       Impact factor: 4.177

6.  Associations between phylogenetic clustering and HLA profile among HIV-infected individuals in San Diego, California.

Authors:  Sanjay R Mehta; Sergei L Kosakovsky Pond; Jason A Young; Douglas Richman; Susan Little; Davey M Smith
Journal:  J Infect Dis       Date:  2012-03-23       Impact factor: 5.226

7.  Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection.

Authors:  Maile Y Karris; Christy M Anderson; Sheldon R Morris; Davey M Smith; Susan J Little
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

8.  Rapid Sequencing of Complete env Genes from Primary HIV-1 Samples.

Authors:  Melissa Laird Smith; Ben Murrell; Kemal Eren; Caroline Ignacio; Elise Landais; Steven Weaver; Pham Phung; Colleen Ludka; Lance Hepler; Gemma Caballero; Tristan Pollner; Yan Guo; Douglas Richman; Pascal Poignard; Ellen E Paxinos; Sergei L Kosakovsky Pond; Davey M Smith
Journal:  Virus Evol       Date:  2016-07-08

9.  Concurrency and HIV transmission network characteristics among MSM with recent HIV infection.

Authors:  Heather A Pines; Joel O Wertheim; Lin Liu; Richard S Garfein; Susan J Little; Maile Y Karris
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

10.  Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release.

Authors:  Moein Jafari; John Guatelli; Mary K Lewinski
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.